Tokyo, Oct. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062606) titled 'Study of How Moxibustion on the Arms and Legs Affects Body Temperature and Autonomic Function' on Oct. 15.

Study Type: Interventional

Study Design: Basic Design - Cross-over Randomization - Randomized Blinding - Open -no one is blinded Control - Placebo

Primary Sponsor: Institute - Morinomiya University of Medical Sciences

Condition: Condition - Healthy Volunteers Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - he objective of this study is to clarify the effects of moxibustion stimulation at acupoints located over arteries on the dorsum of the hands and feet on skin temperature, core temperature, and autonomic nervous system activity. In particular, the study aims to investigate the potential of these acupoints as effective stimulation sites and conditions for inducing a reduction in core temperature of at least 0.2 C. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Moxibustion condition: Two moxa units (SenNenKyu Miracle Soft Smokeless Type) are applied to each of the following bilateral acupoints: LI4, LI5, SI5, LR3, ST42, and ST41. Participants ignite the moxa themselves and remove it when the warming sensation disappears. If excessive heat is perceived, the moxa is removed immediately. The intervention is performed once. Interventions/Control_2 - Control condition: Moxa units are applied to the bilateral LI4, LI5, SI5, LR3, ST42, and ST41 acupoints without ignition. The moxa units are attached for 9 minutes, replaced, and attached for an additional 9 minutes. The attachment duration is based on the average burning time of the moxa obtained in a preliminary experiment. The intervention is performed once.

Eligibility: Age-lower limit - 18 years-old = Gender - Male and Female Key inclusion criteria - 1.Students or staff members of Morinomiya University of Medical Sciences 2.Healthy adults aged 18 to 65 years 3.Individuals who provide written informed consent after receiving a full explanation of the study Key exclusion criteria - 1.Individuals with sleep disorders 2.Individuals with cardiovascular diseases 3.Individuals with autonomic nervous system disorders 4.Individuals taking medications that may affect sleep or thermoregulation 5.Individuals judged by the investigators to be unsuitable for participation in the study Target Size - 20

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 10 Month 01 Day Anticipated trial start date - 2026 Year 10 Month 15 Day Last follow-up date - 2028 Year 12 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071665

Disclaimer: Curated by HT Syndication.